Method for Correcting Matrix Effects in Quantitative Mass Spectrometry of Analytes in Complex Matrices

By adding test matrix and column to the LC-MS technology, the ionization efficiency changes caused by matrix effects are solved, and the accurate quantities and relative/absolute concentration comparison of analytes are achieved, suitable for complex samples and metabolites. Analysis reduces the complexity of cost and data comparison.

CN113196052BActive Publication Date: 2024-11-26LEIDEN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980083317.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-11-16
Filing Date
2019-11-18
Publication Date
2024-11-26
Estimated Expiration
2039-11-18

AI Technical Summary

Technical Problem

In existing LC-MS technologies, matrix effects lead to changes in ionization efficiency, affecting the quantitative accuracy of analytes, especially when targetless analysis and data comparison between instruments, there is a lack of effective correction methods, especially when target analytes are unknown. Or when it is expensive.

Method used

By adding test matrix before the ionization source, changing the composition and concentration of sample matrix, using a matching post-column injection internal standard (PCI-IS) to induce and correct matrix effects and store and apply its response data to other samples, Accurate correction of analyte peak response.

Benefits of technology

Improves the quantitative accuracy and reliability of analytes, and can compare the concentrations of compound in different samples and convert them to absolute concentrations without the need for internal standards for stable isotope labeling, suitable for quantification of complex samples and metabolites.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113196052B_ABST
    Figure CN113196052B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for quantifying one or more analytes in a sample by an analytical system, the analytical system comprising a separation unit (LC column), a device for adding a post-column solution (connector) and a detection unit, the detection unit comprising a mass spectrometer coupled via an ionization source, the method comprising: (i) inducing matrix effects for analytes in the sample and post-column injected internal standards (PCI-IS); (ii) matching one or more post-column injected internal standards (PCI-IS) that best match the response of the analyte to the matrix effect to each analyte, and (iii) storing the analyte-matched PCI-IS identity and optionally associated response data in a library; and (iv) applying the analyte-matched PCI-IS to analytes in other samples to correct for the peak response of the analyte to the matrix effect during ionization, and optionally using the response data to obtain (absolute) quantification of the analyte.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the fields of analytical chemistry and quantitative mass spectrometry (MS), and more particularly to methods of correcting measurement data for variations in ionization efficiency caused by a sample matrix in order to obtain information on the relative or absolute amounts of compounds in the sample, which is independent of the sample matrix. Background Art

[0002] Liquid chromatography-mass spectrometry (LC-MS) is currently the most widely used analytical technique for analyzing organic compounds in different fields, such as environmental analysis, food analysis, bioanalysis or metabolomics. Due to its high selectivity, high sensitivity and high throughput, this technique is also increasingly used in clinical laboratories. The high selectivity provided by mass spectrometry detectors allows the development of analytical methods with minimal sample handling and high throughput analysis, because complete LC separation is often not required as the only discriminator.

[0003] However, it has been found that even if no interferents are identified that affect the selectivity of the method, co-eluting compounds can affect the ionization of the analyte and thus alter or inhibit its quantification. The effect in ionization (which can be positive, i.e., ion enhancement, or negative, i.e., ion suppression) is called matrix effect and is currently one of the major problems in LC-MS, especially from a quantitative point of view. Although many theories have been proposed to explain matrix effects, the exact mechanism remains unexplained and complex. However, for electrospray ionization, it is known that the ionization efficiency of the analyte is highly dependent on its physicochemical properties, as pointed out by: Annesley TM, Ion Suppression in Mass Spectrometry. Clin Chem. 2003; 47(7): 1041-4, and King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. Mechanistic investigation of ionization suppression in electrosprayionization. J Am Soc Mass Spectrom. 2000; 11(11): 942-50.

[0004] On the one hand, molecules with high ionization potential are more easily ionized, and on the other hand, molecules with high surface affinity are more likely to contact excess charges in the surface of the droplet.

[0005] Likewise, coeluting compounds can affect the ionization process to varying degrees, either in the liquid phase by affecting droplet formation, hindering solvent desolvation or competing for excess charge, or in the gas phase via proton exchange. In either case, ion suppression or enhancement processes occur in the ionization source, and therefore the type of ionization source used and its design can influence matrix effects.

[0006] Therefore, matrix effects change the ionization efficiency by the presence of co-eluting substances. One problem with matrix effects in LC-MS is that it is invisible in the chromatogram itself, but has a deleterious effect on the accuracy and sensitivity of the analytical method. Matrix effects often become particularly problematic when comparing quantitative results between analytes in different sample sources. High variability in compound types and quantitation in different sources is often accompanied by high relative matrix effects, generally leading to unreliable results.

[0007] Another problem with matrix effects is that they depend on analyte concentration and matrix in a nonlinear manner, causing systematic errors (biases) to propagate downward in an uncontrollable, unpredictable, and nonlinear manner, making it impossible for the algorithm to report meaningful statistics as a measure of the quality and reliability of the data processing. In other words, the results of peak processing are not robust and may be unreliable in terms of quantitative results (which depend on the specific experiment or sample composition).

[0008] This problem arises when the same instrument is used, but instrument-to-instrument variations also present problems, particularly for biomarker discovery and analysis, where mass spectrometric data for a large number of analytes from a set of different samples are quantitatively compared to one another for differential analysis.

[0009] The current gold standard for correcting for response differences caused by ion suppression due to co-eluting compounds is to use a stable isotope analog as an internal standard. This stable isotope labeled internal standard (herein referred to as STIL-IS) displays the same physicochemical properties as the unlabeled analog and can be spiked into the sample prior to analysis. Quantification is then performed by determining the response ratio of the target analyte and its STIL-IS.

[0010] However, in untargeted LC-MS analysis, the use of STIL-IS is not possible because the target analyte is often unknown. Even in targeted LC-MS analysis, the use of STIL-IS for each target analyte is often impossible, impractical, or too expensive.

[0011] Furthermore, if several related compounds are analyzed using one STIL-IS (as is often done), the internal standard correction will only be valid if the matrix effect is constant over the chromatographic run. However, this is not often the case, and therefore, the matrix effect may be extremely different for the STIL-IS and the other target analytes due to their high retention time dependence. In some cases, this retention time dependence even makes the STIL-IS unable to correct for the matrix effect of the analyte, e.g., sometimes in the case of deuterium-based STIL-IS, due to slight changes in retention times caused by deuterium isotope effects.

[0012] Accordingly, it would be desirable and highly advantageous to obtain methods for correcting matrix effects of complex samples in quantitative LC-MS analysis to overcome the above-mentioned deficiencies and disadvantages of the prior art. This would be particularly useful to be able to quantitatively compare the concentrations of compounds between matrices without having to obtain a reference standard or a stable labeled isotope or similar internal standard for each compound, as these are not often available. Even more useful is that these concentrations can be converted into absolute concentrations, making it possible to compare concentration data between instruments and databases. This would be even more helpful for metabolites that were not identified at the time of measurement, but were identified later, and then to quantify them after identification (identification in the sample measured, the measurement being performed before identification of the metabolite).

[0013] Methods for improving quantitation involve the addition of standards after injection into the column to correct for matrix effects. The use of standards or modifiers added post-column has been described before for a number of applications, such as derivatizing compounds, directing fragmentation, or enhancing ionization. WO2016071695 discloses dynamic post-column additions, in which reagents are added to the eluent after separation, which can affect, for example, the ionization efficiency / stability / adduct formation of the target analyte in a time series manner.

[0014] Previous methods have used standard post-column additions to correct for matrix effects of known compounds. For example, in WO-A-2010149595, continuous post-column injections of known target compounds of known concentrations are applied together with the injected sample to allow compensation or correction of the measured output. Stahnke et al., Anal Chem, 2009, 81, 2185-2192 compensated for matrix effects by using 1PCI-IS to monitor post-column injections of materials in multi-residue analysis with LC-MS / MS to correct for a complete set of known and available analytes.

[0015] Matrix effects have been corrected by other means, such as described by Kruve et al., Analytica Chemica Acta 651 (2009) 75-80, which discloses a method to combat matrix effects in LC / ESI / MS: extrapolation dilution without the use of post-column addition.

[0016] Although the methods disclosed herein above have made some progress in improving quantitation, they do not address the problems posed by untargeted analysis, and if there is no ion suppression in the injected sample (but there may be in another sample), none of these methods have an effective way to select the appropriate PC-IS.

[0017] In order to store analytical characteristics associated with appropriate corrections, it is necessary to establish a library of the characteristics being studied. Libraries and collections of information about analytes are often created to improve data quality. US-A-20160203963 discloses a method for mass calibration: a library with one (or more) physicochemical properties of matrix components eluted by a chromatographic run is established. Then, through the chromatography time, the measurement error of the matrix components in the sample is used to correct the error of the same physicochemical properties of the target analyte eluted between known matrix compounds. This library and other libraries have been established to collect the chemical properties of the analytes, but so far they have not been able to provide a solution for the interactions of unknown analytes caused by matrix components that affect quantification.

[0018] It is an object of the present invention to provide an alternative method for correcting sample matrix effects in analytical techniques and a system operating according to said method. Summary of the invention

[0019] According to a first aspect of the present invention, a method for quantifying one or more analytes in a sample by an analytical system is disclosed, the analytical system comprising a separation unit, a device for adding a post-column solution, and a detection unit, the detection unit comprising a mass spectrometer coupled through an ionization source. The method comprises:

[0020] I. Induce matrix effects on analytes in the sample and post-column injected internal standards (PCI-IS) by one or more of the following steps:

[0021] ii. adding one or more test matrices (matrix B) to the eluent after separation and before introduction into the ionization source of a mass spectrometer (referred to herein as post-column);

[0022] ii. changing the composition of the sample matrix (matrix A) by mixing the sample matrix with another test matrix (matrix C);

[0023] iii. changing the concentration of the sample matrix (matrix A);

[0024] as well as

[0025] II. matching one or more post-column injected internal standards (PCI-IS) to each analyte that best matches the analyte's response to matrix effects, and

[0026] III. storing the analyte-matched PCI-IS identification and optionally associated response data in a library; and

[0027] IV. Applying analyte-matched PCI-IS to analytes in other samples to correct the peak response of the analyte for matrix effects during ionization, and optionally using the response data to obtain (absolute) quantification of the analyte.

[0028] According to a second aspect of the invention, analyte-matched PCI-IS can be applied to analytes in other samples to correct for the peak response of the analyte to matrix effects during ionization, resulting in more accurate and, over time, more precise quantification. Thus, in a second aspect, the invention relates to a system for determining the structure and / or quantification of one or more analytes in a sample, the system comprising:

[0029] V. An analytical system comprising a sample separation unit, a device for adding a solution post-column, and a detection unit comprising a mass spectrometer coupled through an ionization source;

[0030] VI. Optionally used, a unit for inducing a matrix effect on an analyte in a sample;

[0031] VII. Matching one or more post-column injected internal standards (PCI-IS) to each analyte that best matches the response of the analyte to matrix effects, and

[0032] VIII. A library unit that stores analyte-matched PCI-IS identities and optionally associated response data in a library, and

[0033] IX. A processing unit for applying analyte-matched PCI-IS to analytes in further samples to correct for peak responses of the analytes for matrix effects during ionization, and optionally to obtain concentration data for the analytes.

[0034] In a third aspect, the present invention relates to a test matrix composition for determining the structure and / or quantification of one or more analytes in a sample, wherein the composition comprises: one or more salts and / or ionic compounds capable of forming adducts, compounds with surface activity and / or compounds with high proton affinity, and / or a matrix of biological origin, a portion thereof, or other compounds expected to induce matrix effects on the analytes in the sample, in a predetermined concentration, and a suitable solvent or eluent.

[0035] In a fourth aspect, the present invention relates to a kit for use in a system for determining and correcting sample matrix effects on the detection of an analyte in a sample, the kit comprising one or more matrix components, the one or more matrix components comprising one or more salts and / or ionic compounds capable of forming adducts, compounds with surface activity and / or compounds with high proton affinity, and / or a matrix of biological origin, a portion thereof, or other compounds expected to induce a matrix effect on the analyte in the sample, at a predetermined concentration, and a suitable solvent or eluent.

[0036] In a fifth aspect of the present invention, a method for quantifying one or more analytes in a sample by an analytical system is disclosed, wherein the one or more analytes can be features of an unassigned structure, or compounds with a known structure for which no reference material is available, or compounds for which the use of reference materials is impractical due to cost or instability, the analytical system comprising a separation unit, a device for adding a post-column solution, and a detection unit, the detection unit comprising a mass spectrometer coupled through an ionization source, the method comprising:

[0037] X. Induced matrix effects on analytes in the sample and post-column injected internal standards (PCI-IS); and

[0038] XI. matching one or more post-column injected internal standards (PCI-IS) to each analyte that best matches the analyte's response to matrix effects, and

[0039] XII. storing the analyte-matched PCI-IS identification and optionally associated response data in a library; and

[0040] XIII. Apply analyte-matched PCI-IS to analytes in other samples to correct the peak response of the analyte for matrix effects during ionization, and optionally use the response data to obtain (absolute) quantification of the analyte.

[0041] These and other aspects, features and advantages of the present invention will become apparent from the following detailed description of the preferred embodiments and from the independent and dependent claims read in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Embodiments of the present invention are further described hereinafter with reference to the accompanying drawings, wherein like letters and numbers refer to like parts, and wherein the figures in this section illustrate preferred instrument settings, selection of a PCI-IS according to the present invention, responses for calibrating analytes, and actual calibration procedures.

[0043] Figure 1: Schematic overview of a possible instrumental setup for the described matrix effect correction method for quantitative targeted and untargeted mass spectrometric analysis of compounds in complex matrices.

[0044] Figure 2 Schematically represented are the LC-MS results for the case where the analytes in a sample are subject to induced matrix effects and the PCI-IS that best matches the response of the analyte to the matrix effect is found to be selected for PCI-IS correction of analytes in other samples.

[0045] Figure 3 Schematic diagram of the scan-by-scan correction of the analyte signal by the PCI-IS signal.

[0046] Figure 3 The reconstruction of the analyte signal by the PCI-IS signal is schematically shown. Figure 3 A) Scan by scan divided by the PCI-IS signal ( Figure 3 A) to obtain the reconstructed analyte signal ( Figure 3 B) In this figure, PCI-IS 2 is the one that is selected to best match Figure 2 The PCI-IS shows the response of the analyte to the induced matrix effect, therefore the y-axis is defined as the corrected intensity.

[0047] Figure 4 : Principle of correcting matrix effects using post-column injection of internal standards. Extracted ion chromatograms of oleic acid-dl7 in samples where matrix effects were induced by varying the sample matrix (plasma) concentration (A). Extracted ion chromatograms of PCI-ISs FA(16:0)-d31 (B) and LPC(19:0) (C). Reconstructed ion chromatograms of oleic acid-dl7 obtained by dividing the oleic acid-dl7 intensity by the intensity of PCI-IS FA(16:0)-d31 (D) and LPC(19:0) (E) scan by scan.

[0048] Figure 5 The induction of matrix effects on analytes in samples by adding post-column matrix (Matrix B) is disclosed, namely extracted ion chromatograms of samples and five PCI-IS in a conventional analytical run and in a run with induced matrix effects (due to post-column addition of matrix).

[0049] Figure 6 The average peak area of ​​feature 786 in each batch is shown without any correction ( Figure 6 A), with internal standard calibration only ( Figure 6 B), and with PCI-IS Leu-enkephalin and internal standard calibration ( Figure 6 C).

[0050] Figure 7 Shown are selected PCI-IS measurements of analytes in study samples using different batches and sample matrices. Boxplots of the peak response of diclofenac in each study sample relative to the average peak response of diclofenac at the same concentration in academic solution. Boxplots with the same color have the same overall sample matrix. Figure 7 A) shows no correction. Figure 7 B) shows calibration with internal standard only, Figure 7 C) shows the PCI-IS with internal standard calibration. Grey shading is the area within 15% of the preferred value of 100%. DETAILED DESCRIPTION

[0051] Unless otherwise specified, all technical and scientific terms used herein have the same meanings as commonly understood by those skilled in the art to which the invention belongs. The terms used in the description of the invention herein are only for the purpose of describing specific embodiments, rather than for limiting the invention.

[0052] The present invention will be described with respect to specific embodiments and with reference to certain drawings, but the present invention is not limited thereto, but only by the claims. Any reference signs in the claims should not be interpreted as limiting the scope. The drawings described are only schematic and non-restrictive. In the drawings, for illustrative purposes, the size of some elements may be exaggerated and not drawn to scale. The use of the term "comprising" in this specification and claims does not exclude other elements or steps. When an indefinite or definite article is used to refer to a singular noun, for example "a" or "an", "the" includes the plural of that noun, unless otherwise specifically stated.

[0053] In addition, the terms "first", "second", "third", etc. in the specification and claims are used to distinguish similar elements and are not necessarily used to describe a sequential or chronological order. It should be understood that the terms so used are interchangeable under appropriate circumstances, and that the embodiments of the invention described herein are capable of operation in other sequences than described or illustrated herein.

[0054] The following terms or definitions are provided only to aid in the understanding of the present invention. These definitions should not be interpreted as having a scope less than that understood by a person of ordinary skill in the art.

[0055] As used herein, the term "analyte" refers to a substance to be detected and / or quantified in the methods of the present invention.

[0056] As used herein, the term "sample" refers to a composition comprising a matrix (ie, the sample matrix) in which the target analyte is present.

[0057] As used herein, the term "sample matrix effect" refers to the effect of the sample matrix on the ionization of an analyte in the sample.

[0058] The term "sample matrix" is understood to mean compounds present in the sample that are not the analyte.

[0059] The term "matrix" is understood to mean a composition that includes one or more compounds but is essentially free of the target analyte. These components may include endogenous components such as phospholipids, carbohydrates, and endogenous metabolites; residual formulation components from intraperitoneal, intravenous, or oral administration experiments; for example, polyethylene glycol, polysorbate; co-eluting drug metabolites; concomitant drugs used and / or mobile phase additives or solvents, which may show interactions with the target analyte; or contaminants from sample manipulation or treatment.

[0060] The term "test matrix" refers to a matrix other than a sample matrix.

[0061] In the matrix used in the present invention, the components can be advantageously selected so that they are known and in a defined concentration. Suitable matrices according to the present invention include solvents or combinations of solvents that do not substantially induce matrix effects on the analyte, and / or one or more salts and / or ionic compounds capable of forming adducts, and / or one or more compounds with surface activity, and / or one or more compounds with high proton affinity, and / or one or more matrices of biological origin or parts thereof, and / or other compounds expected to induce matrix effects on the analyte in the sample.

[0062] In the context of this specification, when added to the eluent after separation and before introduction into the ionization source of the mass spectrometer, i.e. for post-column matrix addition, the test matrix is ​​referred to herein as matrix B. Where the sample matrix (also referred to as matrix A) is replaced by or added to one or more other matrices, wherein the analytes, their stable isotopes and / or other non-endogenous analogs are spiked into this matrix, these are referred to as test matrix C or matrix C.

[0063] The term "correcting for sample matrix effects" is understood as adjusting the response of the analyte in the sample to compensate for sample matrix effects during ionization.

[0064] The term "post-column injected internal standard (PCI-IS)" is understood to mean an internal standard added to the eluent after separation and before introduction into the ionization source of the mass spectrometer; wherein a suitable addition unit is called "post-column addition device" for the standard or test matrix.

[0065] The present invention provides methods, tools and systems for correcting sample matrix effects according to the methods of the present invention. The present invention is based on the observation that the components of the sample matrix can affect the detection of analytes and especially the quantification of analytes. The analyte may be known, or unknown, or known but no suitable standard is available for determining the concentration using a calibration experiment.

[0066] This influence of the sample matrix can be determined by comparing the effects of different test matrices and by correlating them under the same conditions and finally by correcting the measured values ​​using the most likely applicable correction value, thereby ensuring a more accurate and reliable detection and / or quantification of the analyte in the sample.

[0067] The source of sample matrix effects determined by the methods of the invention are variable and will depend on the nature of the sample.

[0068] It is contemplated according to the present invention that the sample in which the analyte is detected includes a sample from a biological material and a composition derived from or extracted from such a biological material. The sample may be any preparation comprising the analyte to be detected. The sample may include, for example, all or several components of a body tissue or fluid, such as, but not limited to, blood, including plasma and platelet fractions, cerebrospinal fluid, mucus, sputum, saliva, semen, feces or urine or any portion thereof.

[0069] Exemplary samples may include materials derived from whole blood, red blood cells, white blood cells, hair, nail and cuticle material, swabs, including but not limited to oral swabs, throat swabs, vaginal swabs, urethral swabs, cervical swabs, throat swabs, rectal swabs, lesion swabs, abscess swabs, nasopharyngeal swabs, etc., lymphatic fluid, amniotic fluid, cerebrospinal fluid, peritoneal effusion, pleural effusion, cystic fluid, synovial fluid, vitreous fluid, aqueous humor, synovial fluid, eye wash fluid, eye aspirate, plasma, serum, lung lavage fluid, lung aspirate, biopsy material of any tissue in the body, and lysates, extracts or materials obtained from any of the above exemplary biological samples.

[0070] Tissue culture cells, including explant material, primary cells, secondary cell lines, etc., and lysates, extracts, supernatants or materials obtained from any cell, tissue or organ are also within the meaning of the term biological sample as used herein. Samples including microorganisms and viruses are also contemplated in the context of analyte detection using the methods of the present invention. Materials obtained from forensic environments are also within the intended meaning of the term "sample".

[0071] Samples may also include food and beverages, cosmetics, environmental samples such as water, soil, sand, air samples, etc., wherein it should be noted that none of the above lists are intended to be exhaustive.

[0072] The method of the present invention is a method for the detection of an analyte. The nature of the analyte to be detected is not critical to the present invention, and may be any target molecule or aggregate of molecules for detection. A non-exhaustive list of analytes includes proteins, polypeptides, peptides, amino acids, nucleic acids, oligonucleotides, nucleotides, nucleosides, carbohydrates, polysaccharides, lipopolysaccharides, glycoproteins, lipoproteins, nucleoproteins, lipids, hormones, steroids, growth factors, cytokines, neurotransmitters, receptors, enzymes, antigens, allergens, antibodies, metabolites, cofactors, nutrients, toxins, poisons, drugs, biological warfare agents, biohazard agents, infectious agents, prions, vitamins, immunoglobulins, albumins, hemoglobin, coagulation factors, interleukins, interferons, cytokines, peptides including tumor-specific epitopes, and antibodies to any of the above substances. Analytes may include one or more complex aggregates such as, but not limited to, viruses, bacteria, microorganisms such as Salmonella, Streptococcus, Legionella, Escherichia coli, Giardia, Cryptosporidium, Rickettsia, spores, molds, yeasts, algae, amoeba, dinoflagellates, single-celled organisms, pathogens or cells, as well as cell surface molecules, fragments, parts, components, products, small organic molecules, nucleic acids and oligonucleotides, metabolites of microorganisms.

[0073] Typical compounds and conditions that are often present in a sample or semi-purified fraction of a sample may cause sample matrix effects. However, identifying the inducing factors of sample matrix effects is not critical to the present invention.

[0074] The process of the invention can advantageously be performed in several different ways to induce matrix effects of the analyte in the sample. Three methods are mainly distinguished here, which can be used alone or in combination:

[0075] A. adding one or more test matrices (matrix B) to the eluent after separation and before introduction into the ionization source of the mass spectrometer (referred to herein as post-column);

[0076] B. changing the composition of the sample matrix (matrix A) by mixing the sample matrix with another test matrix (matrix C);

[0077] C. Changing the concentration of the sample matrix (matrix A)

[0078] In either case, i.e. whether the analysis is performed with or without induced matrix effects, one or more PCI-IS are injected. Moreover, in addition to the use of one or more PCI-IS, it may be advantageous to also add one or more internal standards to the sample during sample preparation. Preferably, these can be used to correct for variability in sample preparation and / or sample injection volume. Preferably, these should also be corrected by the PCI-IS.

[0079] Figure 1Schematically illustrated is a preferred instrumental setup for a method for matrix effect correction in the quantitative mass spectrometry of analytes in complex matrices.Preferably, there is a separation unit, which comprises, for example, a liquid chromatography unit.Preferably, the ionization source is an electrospray ionization source.

[0080] Preferred methods according to the present invention include a method wherein the induction of a matrix effect in step (a) of claim 1 comprises one or more of the following steps:

[0081] D. adding one or more test matrices (matrix B) to the eluent after separation and before introduction into the ionization source of a mass spectrometer (referred to herein as post-column);

[0082] E. changing the composition of the sample matrix (matrix A) by mixing the sample matrix with another test matrix (matrix C);

[0083] F. Changing the concentration of the sample matrix (matrix A)

[0084] Preferably, in step (D), the one or more matrices comprise at least one compound, or a plurality of compounds, to be expected to induce a matrix effect on the analyte in the sample. Advantageously, the test matrix is ​​selected from: one or more salts and / or ionic compounds capable of forming adducts, and / or compounds with surface activity, and / or compounds with high proton affinity, and / or a matrix of biological origin, a portion thereof, and / or one or more other compounds expected to induce a matrix effect on the analyte in the sample.

[0085] Preferably, in (E), the test matrix (matrix C) comprises a solvent or a combination of solvents that essentially does not induce matrix effects on the analyte, or a matrix of biological origin, a portion thereof and / or one or more compounds expected to induce matrix effects on the analyte in the sample.

[0086] More preferably, the present invention also relates to a method for determining for each analyte the PCI-IS that best matches the response of the analyte to the matrix effect, comprising:

[0087] G. determining a signal for each analyte in the sample, such as a peak area, reconstructed from: each PCI-IS, and preferably an internal standard added before or during sample preparation, optionally with or without induced matrix effects, as described above; and

[0088] H. Based on (G), evaluate which PCI-IS best matches the response of the analyte to induced matrix effects.

[0089] Advantageously, the method of determining the reconstructed signal of each PCI-IS and internal standard for each analyte with and without induced matrix effects comprises one or more of the following steps:

[0090] I. Optionally, one or more internal standards are added to the sample prior to analysis;

[0091] J. The analytes of the sample are subjected to the analytical system while adding one or more post-column PCI-IS (solution) to the eluent;

[0092] K. subjecting the analytes of the replicate samples to the analytical system while inducing matrix effects by applying one or more of the procedures specified herein above;

[0093] L. In the same analytical run, divide the scan-by-scan analyte signal (or intensity) by the PCI-IS signal (or intensity) in each sample to obtain the PCI-IS reconstructed analyte signal (or peak response);

[0094] M. Optionally, in the same measurement run, dividing the signal (or intensity) of the scan-by-scan internal standard (which is added to the sample prior to analysis) by the signal (or intensity) of its matching PCI-IS to derive a PCI-IS corrected internal standard signal (or peak response);

[0095] N. Optionally, in the same measurement run, the PCI-IS reconstructed analyte signal (or peak response) is divided by the applicable PCI-IS corrected internal standard signal (or peak response) to yield the PCI-IS and internal standard reconstructed peak responses.

[0096] Preferably, the internal standard added to the sample during sample preparation comprises a structural analog of PCI-IS and / or a stable isotope labeled version of PCI-IS.

[0097] Preferably, in steps (L) and / or (M) and / or (N), a smoothing algorithm or an averaging algorithm is applied to the signal.

[0098] Preferably, evaluating for each analyte which PCI-IS best matches the response of the analyte to the induced matrix effects comprises: selecting a PCI-IS based on the accuracy value for , preferably by comparing the analyte response in a sample with matrix B or matrix C with a measurement obtained without matrix B or matrix C.

[0099] Preferably, evaluating for each analyte which PCI-IS best matches the response of the analyte to induced matrix effects comprises selecting a PCI-IS based on a value of the precision of the peak response of the analyte reconstructed by the PCI-IS (and optionally an internal standard) across the matrix and / or sample.

[0100] Advantageously, the PCI-IS is selected based on its ability to increase the linear dynamic range of the analyte and / or based on a value of accuracy and / or based on a value of precision.

[0101] Preferably, the PCI-IS that best matches the response of the analyte to the induced matrix effect is stored in a library cell for later use.

[0102] Preferably, applying the PCI-IS matching the analytes in the library to the analytes in other samples comprises the steps of:

[0103] O. optionally adding no, one or more internal standards to the sample prior to analysis;

[0104] P. The analyte of the sample is subjected to an analytical system;

[0105] Q. Add one or more post-column PCI-IS (solution) to the eluate;

[0106] R. matching the analyte signal found in the sample with the analyte stored in the library cell;

[0107] S. Reconstruct the mass spectrometric response of each analyte in the sample for matrix effects using the matched PCI-IS and optional internal standards in the library cells as detailed above in steps L to N to obtain the (final) PCI-IS and internal standard corrected peak responses.

[0108] Preferably, retrospective data processing is applied to correct for matrix effects of the analyte using a PCI-IS that is found in later experiments to be suitable for correction for this analyte.

[0109] Preferably, prospective or retrospective data processing is applied for absolute quantification of the measured analytes using a PCI-IS calibration based on a PCI-IS found suitable for correcting matrix effects and a calibration series for analytes that have been measured at least once using PCI-IS.

[0110] The process preferably includes selecting the PCI-IS that best matches the response of the analyte to the matrix effect.To select the PCI-IS that best matches the response of the analyte to the matrix effect, a matrix effect is induced by changing the matrix in the sample or adding a post-column matrix (matrix B).

[0111] Preferably, multiple test matrices are used to induce matrix effects on analytes in a sample, wherein the induced effects of individual test matrices on the analytes are used for (a) at least partial structural recognition classification or another partial recognition of the analytes; and / or (b) optimizing the selection of a PCI-IS or a combination of PCI-ISs that best matches the response of the analyte to the induced matrix effects.

[0112] Preferably, an LC method is used to separate the sample containing the analyte by passing it through an LC column, and then connecting the flow to a flow containing the PCI-IS solution with or without matrix B. The PCI-IS solution flow can be provided by any suitable means, such as, for example, an LC pump or a syringe pump. The combined flow is then directed to the ionization source ( Figure 1 ). In a preferred test matrix composition for determining the structure and / or quantification of one or more analytes in a sample, the composition comprises one or more salts and / or ionic compounds capable of forming adducts, compounds having surface activity, and / or compounds having high proton affinity, and / or a matrix of biological origin, a portion thereof, or other compounds expected to induce a matrix effect on the analytes in the sample, in a predetermined concentration, and a suitable solvent or eluent.

[0113] The invention also relates to a method, wherein the PCI-IS signal or the signal ratio between analyte and PCI-IS is used for quality control purposes.

[0114] The present invention relates to a kit for use in a system for determining and correcting sample matrix effects on the detection of an analyte in a sample, the kit comprising one or more matrix compositions comprising one or more salts and / or ionic compounds capable of forming adducts, compounds having surface activity, and / or compounds having high proton affinity, and / or a matrix of biological origin, a portion thereof, or other compounds expected to induce a matrix effect on the analyte in the sample, in a predetermined concentration, and a suitable solvent or eluent.

[0115] In addition, the present method can be used to induce matrix effects into unknown samples containing analytes that have not yet been identified, or analytes whose structures are known but for which a calibration model has not yet been established using PCI-IS, which once the calibration model has been measured using PC-IS, the measured data is later used to quantify the absolute amount. The concentration of identified compounds can be estimated by using the calibration model of analytes with similar structures (which are used to expect or predict that their ionization efficiency is similar). In fact, for such an estimate, the exact structure of the analyte does not have to be known, but the compound must be sufficiently characterized to estimate the response factor.

[0116] The following examples will now be used to describe typical systems in which the present invention may be used, illustrating the value of the present invention in both targeted and untargeted analysis.

[0117] Example 1: Selecting the best matching PCI-IS in actual situations

[0118] Background: In LC-MS analysis of fatty acids, an internal standard is often spiked into the sample and used to calibrate multiple fatty acids, which can lead to inaccurate results if matrix effects vary with retention time. Here, we investigated the possibility of using PCI-IS to calibrate matrix effects for an exemplary fatty acid (oleic acid-d17). This example focuses on selecting the best matching PCI-IS from two tested PCI-ISs.

[0119] Methods and Results: A solution of oleic acid-dl7 in IPA was added to the dried supernatant of the protein precipitate of plasma in various volumes (10, 20, 30, 40 and 50 uL). Window A shows the extracted ion chromatogram (EIC) of oleic acid-dl7. It shows that increasing the concentration of plasma (matrix A) has an inhibitory effect on the response of oleic acid-dl7. Two PCI-IS: FA(16:0)-d31 (with EIC in Window B) and LPC(19:0) (with EIC in Window C) were injected. Window D shows the peak response of the PCI-IS FA(16:0)-d31 reconstruction of oleic acid-dl7, and Window E shows the peak response of the LPC(19:0) reconstruction of oleic acid-dl7.

[0120] Figure 4 The principle of matrix effect correction using post-column injection of internal standards is shown.

[0121] Figure 4 The principle of inducing a matrix effect on the analyte in the sample by varying the concentration of the sample matrix in the injection solution (claim 2d) (pane A, pane B and pane C) and the principle of the correction effect of two post-column injected internal standards (pane D and pane E) are shown.

[0122] Here, the extracted ion chromatograms of oleic acid-dl7 in samples where matrix effects were induced by varying the sample matrix (plasma) concentration (A) are shown. The extracted ion chromatograms of PCI-IS FA(16:0)-d31 (B) and LPC(19:0) (C) are shown. The reconstructed ion chromatogram of oleic acid-dl7 was obtained by dividing the intensity of oleic acid-dl7 by the intensity of PCI-IS FA(16:0)-d31 (D) and LPC(19:0) (E) scan by scan.

[0123] While the coefficient of variation (CV) of the uncorrected peak area in pane A was 21%, the coefficients of variation of the uncorrected peak area in panes D and E were 4.6% and 9.9%, respectively. Visual assessment also showed that correction of the signal of oleic acid-d17 using FA(16:0)-d31 was more appropriate than no correction or correction using LPC(19:0).

[0124] This example shows that oleic acid-d17 measurements can be easily corrected using FA(16:0)-d31 as the PCI-IS, leading to more accurate results compared to no correction or using LPC(19:0) as the PCI-IS correction.

[0125] Embodiment 2: The application of the present invention to targeted and untargeted analysis is shown, using liquid chromatography coupled to mass spectrometry (LC-MS) to quantify analytes in a sample.

[0126] Background: An untargeted analysis was performed on (micro)biological samples that could be divided into four groups with different biological origins and therefore four different sample matrices. The goal was to detect and quantify features, as well as to be able to compare the quantitative results across all batches and all matrices and between them.

[0127] Methods: To detect features and determine the PCI-IS that best matches the response of the analytes to matrix effects, a sample pool reflecting the complete sample set was created. For this, individual samples were prepared, dried, reconstituted in a solution containing an internal standard (0.25 μg / mL of daidzein-d6) and pooled. They were separated by the following method: Using the LC-MS method, a PCI-IS solution (containing 63.5 ng / mL daidzein, 141.5 ng / mL hydrocortisone, 240.5 ng / mL leucine-enkephalin, 38.2 ng / mL cimetidine and 1428.5 ng / mL bradykinin in acetonitrile / water, 50 / 50, v / v) was injected at a flow rate of 20 μL / min after LC separation and before ionization. Sample analysis was repeated while adding the same PCI-IS solution, but including matrix B (100 μM potassium acetate, 1 μM dodecyltrimethylammonium and 30 μM L-homoarginine) to induce matrix effects.

[0128] The PCI-IS that best corrects for analyte-induced matrix effects is paired with the analyte and stored in a library.

[0129] The library was then applied to the analysis of 14 batches of 46-66 study samples, covering 4 different biological matrices. In addition, a quality control sample (a pooled sample representing all study samples, including all matrices) was analyzed in triplicate in each batch.

[0130] The method includes three components described below and is used to induce matrix effects. It shows the value of using post-column injected internal standards (PCI-ISs) to correct for matrix effects and correct for long-term general instrument response, which is achieved by reducing the variability of analytical results between batches.

[0131] Result: Untargeted Analysis

[0132] Peak detection and matching is performed, first between the same samples with and without matrix B for each sample analyzed, and then between different samples. Since this example is intended to explain the principles of the invention, the focus will be on one (representative) feature detected in one of the samples. This feature is numbered 786. Figure 5 A shows its extracted ion chromatograms along with five PCI-IS in a conventional analytical run and in a run with induced matrix effects (due to post-column addition of matrix). Figure 5 B shows the characteristic 786 peaks reconstructed from each PCI-IS (scan-by-scan division). Figure 5 C shows the EIC of the internal standard (daidzein-d6) and its unlabeled isotope PCI-IS daidzein in the left pane, and the internal standard peak corrected by PCI-daidzein in a conventional analytical run and in an analytical run with induced matrix effects in the right pane. The benefits of using PCI-IS for internal standard correction are clear and obvious. The internal standard daidzein-d6 added to the sample before analysis is used to correct for possible changes in injection volume or sample preparation. In order to select the preferred PCI-IS for feature 786, first, the peak area ( ) of the internal standard daidzein-d6 corrected by PCI-IS is determined with and without induced matrix effects (listed in Table 1). Figure 5 C, right pane). Then, Figure 5 B calculated the peak area of ​​each PCI-IS reconstruction of feature 786 (listed in Table 1), without any correction for the internal standard. At this point, PCI-IS hydrocortisone seems to correct PCI-IS best, with a difference of -4.7% between samples with and without induced matrix effects. However, in order to compensate for the change in injection volume, the peak area of ​​the PCI-IS reconstruction of feature 786 was corrected by the peak area of ​​the PCI-IS correction (meaning divided by it) of the internal standard, resulting in the peak area of ​​the PCI-IS and the internal standard correction. Then again, the peak area corrected in the operation with induced matrix effects was compared with the peak area in the conventional analysis operation. Now, leucine-enkephalin (PCI-IS obtained the smallest difference (-1.9%)) is the best of the five PCI-IS in the correction of induced matrix effects, and is therefore stored in the library to correct feature 786 in future sample analysis.

[0133] The value of PCI-IS became clear when applied to the analysis of these subsequent samples in the study, where actual samples were measured. Feature 786 was detected in quality control (QC) samples, which were measured in triplicate in each of the 14 batches. Figure 6The average peak area of ​​feature 786 for each batch is shown: without any correction ( Figure 6 A), calibrated only by internal standards ( Figure 6 B), and by PCI-IS leucine-enkephalin and internal standard calibration ( Figure 6 C). It shows how the PCI-IS and internal standard calibration method can reduce the batch-to-batch variation (%CV) from 16% to 8%, and on top of that, how it corrects for the trend observed in the uncorrected peaks, which gives relatively small areas in batches 1-7 and larger areas in batches 8-14. On the other hand, Figure 3 The curve in B shows that similar results are obtained when only the internal standard is used, with a %CV between batches of 8%. This raises the question of whether using only the internal standard is not sufficient. This may indeed be sufficient in cases where one QC sample is measured in multiple batches where the matrix of the samples is the same, since it is the same sample. The real value of using PCI-IS calibration is its ability to correct for matrix effects, which can only be demonstrated when comparing different samples, as in the targeted analytical examples described in the following section. Figure 5 Shown are matrix effects induced on the analytes in the sample by the addition of post-column matrix (Matrix B).

[0134] Figure 5 A) Shows the extracted ion chromatograms of feature 786 and five PCI-IS standards in samples without induced matrix effects (continuous line) and with induced matrix effects (broken lines) analyzed by post-column injection of matrix B. B) Reconstructed peaks of feature 786 after correction by each of the PCI-IS in samples without induced matrix effects (continuous line) and with induced matrix effects (broken lines) analyzed by post-column injection of matrix B. C) In the left pane, extracted ion chromatograms of the spiked internal standard (daidzein-d6) and non-isotopically labeled PCI-IS daidzein, and in the right pane, the corrected peaks in samples without induced matrix effects (continuous line) and with induced matrix effects analyzed by post-column injection of matrix B.

[0135] The selection of PCI-IS that best matches the response of the analyte to induced matrix effects is shown in Table 1. The peak response was calculated by summing the corrected intensities between the 10% of the highest corrected signal of the peak and subtracting the difference between the first and last of these intensities to subtract the (potential) baseline.

[0136] Table 1: Selection of PCI-IS that best matches the response of the analyte to induced matrix effects.

[0137]

[0138] Figure 6 Analytes measured in different batches of QC samples using selected PCI-IS are shown. The peak response of feature 786 in each QC sample is relative to the average peak response of all QC samples in the 14 batches, thus, Figure 6 A) shows the response without any correction, and Figure 6 B) shows the response with internal standard calibration only, and 6C) with PCI-IS and internal standard calibration. The shaded area indicates the area within 15% of the 100% preferred value.

[0139] Example 3: Targeted Analysis

[0140] As part of the quality control measures, a known analyte, diclofenac, was spiked into all study samples at the same concentration prior to analysis. The preferred PCI-IS for diclofenac was selected in this example by the same procedure as described previously for the untargeted analysis and was found to be leucine-enkephalin. The peak area of ​​diclofenac in each study sample (46-66 study samples per batch) was divided by the total average peak area of ​​diclofenac for academic solutions of the same concentration as the samples (measured repeatedly before and after each study batch) to obtain the relative peak area. This was done without any calibration ( Figure 7 A), only IS correction ( Figure 7 B) and both PCI-IS and IS corrections have ( Figure 7 C).

[0141] Calculated over 14 batches, the average relative peak response ± standard deviation was 112% ± 15 (without any correction), 110% ± 7.3% (IS correction only), and 106% ± 3.0% (both PCI-IS and IS corrections). Figure 7The curve graph in does show that the correction with PCI-IS and internal standards minimizes the variation between batches of samples with similar and / or different sample matrices, and brings the peak response closer to the peak response in the academic samples. The 6% difference between the peak responses of PCI-IS and IS corrections in the research samples and the academic samples can be explained by the fact that diclofenac can be adsorbed to sites that may be occupied when the sample matrix is ​​present, such as vials during sample preparation. Although the use of PCI-IS and IS corrections reduces the variation between batches, the variation within the batch is increased due to the introduction of additional error sources. It is expected that this can be further optimized by, for example, reducing the variation in the PCI-IS signal that is related to non-matrix effects (e.g., by stabilizing the PCI-IS flow, optimizing the mixing with the eluent and / or applying a smoothing or averaging algorithm to the signal). In addition, more than one internal standard can be used. In this example, the addition of additional internal standards may have reduced the variability in batch 6, which was mainly caused by the variability in the internal standard response that is not related to matrix effects.

[0142] This example illustrates that the PCI-IS calibration according to the invention makes it possible to quantify and compare analytes in samples from different matrices in different analytical batches, without the need for a stable isotope labeled internal standard for each analyte. Still further, calibration with PCI-IS and internal standards allows the use of a single calibration curve to make possible the absolute quantification of analytes in a variety of matrices, which were prepared in only one matrix, perhaps even academically, provided that sample matrix effects unrelated to ionization (e.g. solubility of the analyte in the matrix or adsorption to the walls of the preparation vial) are unimportant or not taken into account. This would result in a significant saving in analytical time and cost, since it would render redundant the calibration lines run in each batch.

[0143] Figure 7 Analytes measured in study samples applying selected PCI-IS to different batches and sample matrices are shown. Boxplots of the peak response of diclofenac in each study sample relative to the average peak response of diclofenac at the same concentration in academic solution. Boxplots with the same color have the same overall sample matrix. Figure 7 A) shows no correction. Figure 7 B) shows internal standard calibration only, and Figure 7 C) shows the PCI-IS with internal standard calibration. The grey shaded area represents the area within 15% of the preferred value of 100%. Figure 7 In +The symbol indicates an outlier above 160%. In batch 9 of Figure A: 163%; in batches 1 and 5 of Figure B: 196% and 667%, respectively (these are caused by the incorrect determination of the peak area of ​​the internal standard d); in batches 1 and 5 of Figure C: 187% and 727%, respectively (this is caused by the incorrect determination of the peak area of ​​the internal standard). The * symbol indicates an outlier that exceeds 1.5x the interquartile range, but is less than 160%.

[0144] The above experiments show the effectiveness of the present method in allowing correction for matrix effects.

Claims

1. A method for quantifying one or more analytes in a sample by an analytical system comprising a separation unit, a device for adding a post-column solution, and a detection unit, wherein the detection unit comprises a mass spectrometer coupled through an ionization source, the method comprising: a. Induce matrix effects for analytes in the sample and internal standard PCI-IS injected post-column by the following steps: i. adding one or more test matrices to the eluent after separation and before introduction into the ionization source of a mass spectrometer; ii. changing the composition of the sample matrix by mixing the sample matrix with other test matrices; and / or iii. Changing the concentration of the sample matrix; as well as b. matching one or more post-column injected internal standards PCI-IS to each analyte that best matches the analyte's response to matrix effects, and c. storing the analyte-matched PCI-IS identifier in a library and optionally storing the associated response data in a library; as well as d. Apply analyte-matched PCI-IS to analytes in other samples to correct for analyte peak response for matrix effects during ionization, and optionally use the response data to obtain quantification of the analyte.

2. The method according to claim 1, wherein: The analyte can be a feature for which no structure has been assigned; or a compound with a known structure for which no reference material is available; or a compound for which the use of reference materials is impractical due to cost or instability; Or it is a compound with a known structure and available reference materials.

3. The method according to claim 1 or 2, wherein: The separation unit is configured and operable to generate a liquid flow, and includes a liquid chromatography unit, a supercritical fluid chromatography unit, and / or an online solid phase extraction unit.

4. The method according to claim 1 or 2, wherein: The ionization source was an electrospray ionization source.

5. The method according to claim 1, wherein: In step i, the matrix comprises at least one compound expected to induce a matrix effect on the analyte in the sample.

6. The method according to claim 1, wherein: In step a, one or more salts and / or ionic compounds capable of forming adducts, compounds having surface activity, and / or compounds having high proton affinity, and / or a matrix of biological origin, or a portion thereof, or other compounds expected to induce matrix effects on the analyte in the sample are employed.

7. The method according to claim 1, wherein: In ii, the other test matrix comprises a solvent or combination of solvents that does not substantially induce matrix effects on the analyte, a matrix of biological origin, or a portion thereof, and / or one or more compounds that are expected to induce matrix effects on the analyte in the sample.

8. The method of claim 1, for determining for each analyte the PCI-IS that best matches the response of the analyte to matrix effects, comprising: 8a. Determine for each analyte in the sample a signal which is reconstructed from: Each PCI-IS was performed with and without induction of matrix effects according to step a; 8b. Evaluate which PCI-IS compound or combination of compounds best matches the response of the analyte to induced matrix effects.

9. The method according to claim 8, wherein: The signal is the peak area.

10. The method according to claim 8, wherein: The signal is determined for each analyte in the sample, also comprising reconstruction from the internal standard added before or during sample preparation with and without the induction of matrix effects according to step a.

11. The method of claim 8 for determining each PCI-IS and internal standard reconstruction signal for each analyte with and without induced matrix effects, comprising one or more of the following steps: 11a. Optionally, one or more internal standards are added to the sample prior to analysis; 11b. The analyte of the sample is subjected to the analytical system while adding one or more post-column PCI-IS solutions to the eluent; 11c. inducing a matrix effect while the analytes of the replicate samples are subjected to the analytical system by applying one or more of the procedures specified in step a; 11d. In the same analytical run, the scan-by-scan analyte signal in each sample is divided by the PCI-IS signal to obtain the PCI-IS reconstructed analyte signal; 11e. Optionally, in the same measurement run, the signal of each internal standard scanned is divided by its matching PCI-IS signal to obtain a PCI-IS corrected internal standard signal; 11f. Optionally, in the same measurement run, the PCI-IS reconstructed analyte signal is divided by the applicable PCI-IS corrected internal standard signal to yield the PCI-IS and internal standard reconstructed peak responses.

12. The method according to claim 11, wherein: Internal standards that may optionally be added to samples during sample preparation include: structural analogs of PCI-IS and / or stable isotope labeled versions of PCI-IS.

13. The method according to claim 11, wherein: In steps 11d and / or 11e and / or 11f, a smoothing or averaging algorithm is applied to the signal.

14. The method according to any one of claims 11 to 13, wherein: Evaluating for each analyte which PCI-IS best matches the response of the analyte to the induced matrix effects comprises: selecting a PCI-IS based on the accuracy value, and comparing the peak responses of the PCI-IS of the analyte in the sample and the internal standard reconstruction with and without the induced matrix effects specified in step a.

15. The method according to any one of claims 11 to 13, wherein: Evaluating for each analyte which PCI-IS best matches the response of the analyte to induced matrix effects includes selecting a PCI-IS based on a value of precision, which is the accuracy of the PCI-IS reconstructed peak response of the analyte across matrix and / or sample.

16. The method according to any one of claims 11 to 13, comprising: The PCI-IS is selected based on its ability to increase the linear dynamic range of the analyte and / or based on a value of accuracy and / or based on a value of precision.

17. The method according to any one of claims 11 to 13, wherein: The PCI-IS combination was chosen to best match the response of the analyte to the induced matrix effects.

18. The method according to any one of claims 11 to 13, wherein: The combination of PCI-IS was chosen to best match the response of the analyte to the induced matrix effects in the multivariate approach.

19. The method according to any one of claims 1 or 2 and 11 to 13, wherein: Using multiple test matrices to induce matrix effects on analytes in a sample, wherein the individual test matrix-induced effects on the analytes are used to: a. at least a partial structural identification of the analyte; and / or b. Optimization of the selection of the PCI-IS or combination of PCI-IS that best matches the response of the analyte to induced matrix effects.

20. The method according to any one of claims 11 to 13, wherein: The one or more PCI-IS or combination of PCI-IS that best matches the response of the analyte to the induced matrix effect is stored in a library cell.

21. The method according to claim 20, wherein: A PCI-IS or a combination of PCI-ISs matching an analyte in a library is applied to the analyte, the method comprising the following steps: 21a. Optionally, prior to analysis, one or more internal standards are added to the sample; 21b. The analyte of the sample is subjected to an analytical system; 21c. Add PCI-IS solution to the eluent column; 21d. Matching the analyte signal found in the sample with the analyte stored in the library unit; and 21e. Using the matched PCI-IS in the library cells, reconstruct the mass spectral response of each analyte in the sample as detailed in steps 11d to 11f to obtain the peak responses for the PCI-IS and internal standard correction.

22. The method according to any one of claims 1 or 2 and 11 to 13, wherein: Retrospective data processing was applied to correct for matrix effects of the analyte using a PCI-IS that was found in later experiments to be appropriate for correction for this analyte.

23. The method according to any one of claims 1 or 2 and 11 to 13, wherein: Prospective or retrospective data processing is applied for absolute quantification of the measured analytes using a PCI-IS calibration based on a PCI-IS found to be suitable for correcting matrix effects and reference measurements and calibration series of analytes that have been measured at least once using PCI-IS.

24. The method according to any one of claims 1 or 2 and 11 to 13, wherein: The PCI-IS signal or the signal ratio between analyte and PCI-IS is used for quality control purposes.

25. A system for determining the structure and / or quantity of one or more analytes in a sample, comprising: 25a. An analysis system comprising a sample separation unit and a detection unit, wherein the detection unit comprises a mass spectrometer coupled through an ionization source; 25b. Unit for PCI-IS induced matrix effects for analytes in the sample and internal standards injected post-column by the following steps: i. adding one or more test matrices to the eluent after separation and before introduction into the ionization source of a mass spectrometer; ii. changing the composition of the sample matrix by mixing the sample matrix with other test matrices; and / or iii. Changing the concentration of the sample matrix; 25c. Matching one or more post-column injected internal standards PCI-IS to each analyte that best matches the response of the analyte to matrix effects, and 25d. A library unit for storing analyte-matched PCI-IS identities in a library and optionally associated response data in a library, and 25e. A processing unit for applying analyte matched PCI-IS to analytes in further samples to correct for peak response of the analytes for matrix effects during ionization, and optionally to obtain concentration data for the analytes.

26. A method for quantifying one or more analytes in a sample by means of a system for determining the structure and / or quantification of one or more analytes in a sample according to claim 25, wherein: The analyte can be a compound that has not yet been assigned a structure, or a compound with a known structure for which no reference material is available, or a compound for which the use of a reference material is impractical due to availability or instability, the method comprising: 26a. Induce matrix effects for the analytes in the sample and the internal standard PCI-IS injected post-column by the following steps: i. adding one or more test matrices to the eluent after separation and before introduction into the ionization source of a mass spectrometer; ii. changing the composition of the sample matrix by mixing the sample matrix with other test matrices; and / or iii. changing the concentration of the sample matrix; and 26b. matching one or more post-column injected internal standards PCI-IS to each analyte that best matches the response of the analyte to matrix effects, and 26c. storing the analyte-matched PCI-IS identification in a library and optionally storing the associated response data in a library; and 26d. Apply analyte-matched PCI-IS to analytes in other samples to correct for analyte peak response for matrix effects during ionization, and optionally use the response data to obtain quantification of the analyte.

27. The method according to claim 26, wherein: The separation unit is configured and operable to generate a liquid flow, and includes a liquid chromatography unit, a supercritical fluid chromatography unit, and / or an online solid phase extraction unit.

28. The method according to any one of claims 26 to 27, wherein: The ionization source was an electrospray ionization source.

29. The method according to claim 26, wherein: In step 26a, the matrix includes at least one compound expected to induce a matrix effect on the analyte in the sample.

30. The method of claim 26, wherein: One or more salts and / or ionic compounds capable of forming adducts, compounds having surface activity, and / or compounds having high proton affinity, and / or matrices of biological origin, or parts thereof, or other compounds expected to induce matrix effects on the analytes in the sample are employed.

31. The method of claim 26, wherein: In step 26a, the other test matrix includes: a solvent or combination of solvents that does not substantially induce matrix effects on the analyte, a matrix of biological origin, or a portion thereof, and / or one or more compounds expected to induce matrix effects on the analyte in the sample.

32. The method of claim 26, for determining for each analyte the PCI-IS that best matches the response of the analyte to matrix effects, comprising: 32a determining a signal for each analyte in the sample reconstructed from: each PCI-IS with and, respectively, without the matrix effects induced by step 26a; and 32b Evaluate which PCI-IS compound or combination of compounds best matches the response of the analyte to induced matrix effects.

33. The method of claim 32, wherein: The signal is the peak area.

34. The method of claim 32, wherein: Determining a signal for each analyte in the sample also includes reconstruction from: internal standards added before or during sample preparation in the case where matrix effects are induced in step 26a, and respectively, in the case where no matrix effects are induced in step 26a.

35. The method of claim 32 for determining each PCI-IS and internal standard reconstruction signal for each analyte with and without induced matrix effects, comprising one or more of the following steps: 35a. Optionally, one or more internal standards are added to the sample prior to analysis; 35b. The analyte of the sample is subjected to the analytical system while adding one or more post-column PCI-IS solutions to the eluent; 35c. The analytes of the replicate samples are subjected to the analytical system while inducing matrix effects; 35d. In the same analytical run, the analyte signal scanned in each sample is divided by the PCI-IS signal to obtain the analyte signal reconstructed by PCI-IS; 35e. Optionally, in the same measurement run, the signal of each internal standard scanned is divided by the signal of the matching PCI-IS to obtain the PCI-IS corrected internal standard signal; 35f. Optionally, in the same measurement run, the PCI-IS reconstructed analyte signal is divided by the applicable PCI-IS calibrated internal standard signal to provide PCI-IS and internal standard reconstructed peak responses.

36. The method of claim 35, wherein: Internal standards that may optionally be added to samples during sample preparation include: structural analogs of PCI-IS and / or stable isotope labeled versions of PCI-IS.

37. The method of claim 35, wherein: In steps 35d and / or 35e and / or 35f, a smoothing or averaging algorithm is applied to the signal.

38. A method according to any one of claims 35 to 37, wherein: Evaluating for each analyte which PCI-IS best matches the response of the analyte to the induced matrix effects includes selecting a PCI-IS based on the accuracy value, and comparing the peak responses of the PCI-IS of the analyte in the sample and the internal standard reconstruction with and without the induced matrix effects specified in step 26a.

39. The method according to any one of claims 35 to 37, wherein: Evaluating for each analyte which PCI-IS best matches the response of the analyte to induced matrix effects includes selecting a PCI-IS based on a value of precision, which is the accuracy of the PCI-IS reconstructed peak response of the analyte across matrix and / or sample.

40. A method according to any one of claims 35 to 37, comprising: The PCI-IS is selected based on its ability to increase the linear dynamic range of the analyte and / or based on a value of accuracy and / or based on a value of precision.

41. The method according to any one of claims 35 to 37, wherein: The PCI-IS combination was chosen to best match the response of the analyte to the induced matrix effects.

42. The method according to any one of claims 35 to 37, wherein: The combination of PCI-IS was chosen to best match the response of the analyte to the induced matrix effects in the multivariate approach.

43. The method according to any one of claims 26 or 27 and 35 to 37, wherein: Using multiple test matrices to induce matrix effects on analytes in a sample, wherein the individual test matrix-induced effects on the analytes are used to: 43a. at least a partial structural identification of the analyte; and / or 43b. Optimization of the selection of the PCI-IS or combination of PCI-IS that best matches the response of the analyte to induced matrix effects.

44. The method according to any one of claims 35 to 37, wherein: The one or more PCI-IS or combination of PCI-IS that best matches the response of the analyte to the induced matrix effect is stored in a library cell.

45. The method of claim 44, wherein: A PCI-IS or a combination of PCI-ISs matching an analyte in a library is applied to the analyte, the method comprising the following steps: 45a. Optionally, prior to analysis, one or more internal standards are added to the sample; 45b. The analyte of the sample is subjected to an analytical system; 45c. Add PCI-IS solution to the eluent column; 45d. Matching the analyte signal found in the sample with the analyte stored in the library unit; and 45e. Using the matched PCI-IS in the library cells, reconstruct the mass spectral response of each analyte in the sample as detailed in steps 35d to 35f to obtain the peak responses corrected for the PCI-IS and internal standards.

46. ​​The method according to any one of claims 26 or 27 and 35 to 37, wherein Retrospective data processing was applied to correct for matrix effects of the analyte using a PCI-IS that was found in later experiments to be appropriate for correction for this analyte.

47. The method according to any one of claims 26 or 27 and 35 to 37, wherein: Retrospective data processing was applied to absolutely quantify measured analytes for which reference standards had been made available by using a PCI-IS calibration based on a PCI-IS found to be suitable for correcting matrix effects and a reference measurement and calibration series for the analyte that had been measured at least once using the PCI-IS.

48. The method according to any one of claims 26 or 27 and 35 to 37, wherein: The PCI-IS signal or the signal ratio between analyte and PCI-IS is used for quality control purposes.